KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RMD) EBT Margin (2016 - 2025)

Historic EBT Margin for Resmed (RMD) over the last 17 years, with Q4 2025 value amounting to 34.87%.

  • Resmed's EBT Margin rose 22400.0% to 34.87% in Q4 2025 from the same period last year, while for Dec 2025 it was 33.69%, marking a year-over-year increase of 25400.0%. This contributed to the annual value of 32.6% for FY2025, which is 56000.0% up from last year.
  • Latest data reveals that Resmed reported EBT Margin of 34.87% as of Q4 2025, which was up 22400.0% from 33.45% recorded in Q3 2025.
  • Resmed's 5-year EBT Margin high stood at 34.87% for Q4 2025, and its period low was 22.31% during Q4 2023.
  • For the 5-year period, Resmed's EBT Margin averaged around 28.69%, with its median value being 27.95% (2021).
  • In the last 5 years, Resmed's EBT Margin tumbled by -41600bps in 2023 and then soared by 103200bps in 2024.
  • Quarter analysis of 5 years shows Resmed's EBT Margin stood at 26.52% in 2021, then dropped by 0bps to 26.48% in 2022, then fell by -16bps to 22.31% in 2023, then skyrocketed by 46bps to 32.63% in 2024, then increased by 7bps to 34.87% in 2025.
  • Its EBT Margin was 34.87% in Q4 2025, compared to 33.45% in Q3 2025 and 33.98% in Q2 2025.